|
Product
|
Human LDL-PLA2
|
|
Cat#
|
101-13-140A
|
|
Sequence
|
His-Tag sequence not included: FDWQYINPVAHMKSSAWVNKIQVLMAAASFGQTKIPRGNG PYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFL GTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYS AIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQ EEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDS IDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIP QPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFAT GKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEG DDENLIPGTNINTTNQHIMLQNSSGIEKYN
|
|
Unit/Weight
|
0.01 mg
|
|
Unit Price
|
$228.00
|
|
Description
|
LP-PLA2 is an enzyme produced by inflammatory cells and hydrolyzes oxidised phospholipids in low-density lipoprotein (LDL). LP-PLA2 travels in the blood mainly with LDL and less than 20% is associated with high-density lipoprotein. LP-PLA2 is involved in the development of atherosclerosis and is a marker for cardiac disease. Recombinant LP-PLA2 comprises a 420 amino acid fragment (22-441) corresponding to the mature LP-PLA2 protein and is expressed in E. coli with an amino-terminal hexahistidine tag.
|
|
Molecular Weight
|
52.25 kDa
|
|
Purity
|
Purity > 95% as determined by reducing and non-reducing SDS-PAGE, Bradford assay, Western blot and ELISA.
|
|
Storage
|
Store at -20°C. Product is guaranteed one year from the date of shipment.
|